Clinical Trial Update: Resolution of Sickle Cell Leg Ulcers With Voxelotor [Phase 3]

View source ↗

Summary

A Phase 3 trial of voxelotor for resolution of sickle cell leg ulcers has been terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leg Ulcers
• Sickle Cell Disease

Drugs mentioned

• Voxelotor (voxelotor)

Snippet

Sponsor: Pfizer | Conditions: Sickle Cell Disease, Leg Ulcers | Phase 3 | Status: TERMINATED | Results posted: 2025-07-09